Aurobindo Pharma Limited

Plot No.# 2
Maitri Vihar, Ameerpet
Hyderabad 500038

Aurobindo Pharma Limited - - Company Summary

Manufacturers and Exporters of some of the most quality conscious Active Pharmaceutical Ingredients (bulk actives), intermediates, Peptides and speciality generic formulations.
Manufactures of semi synthetic penicillins and cephalosporins.
Manufacturer of Bulk Drugs, Intermediates & Formulations such as Antibiotic Penicillins, Antibiotic Cephalosporins, Anti - Microbials, Anti - Microbials - Quinolones, Macrolides, Sunfonamides, Antiprotozoals, Cardiovasculars, Anti Ashthmatics, Anti Fungals, Sterile - Parenterals, Fluroquinolo
Product Profile:
ANTI-DEPRESSANTS: Citalopram HBr, Bupropion HCl, Fluoxetine HCl,Gabapentin, Melitracin HCl, Mirtazapine, Paroxetine HCl, Risperidone, Sertraline HCl.
ANTI-CONVULSANTS- Leviteracetam,Topiramate.
HYPNOTICS & ANTI-PSYCHOTICS-Flupenthixol,Olanzapine,Zolpidem,Quetiapine,Zaleplon.
ANTI-HYPERTENSIVES-Benazepril, Fosinopril, Lisinopril, Perindopril, Quinapril, Ramipril, Trandolapril, Losartan Potassium.
BETA BLOCKERS- Bisoprolol Fumarate, Carvedilol.
THIAZIDE DIURETIC- Hydrochlorothiazide.
ANTI-THROMBOTIC - Clopidogrel bisulfate, Pentoxifylline.
STATINS- Atorvastatin Calcium, Fluvastatin, Simvastatin.
ANTI-DIABETICS- Gilbenclamide, Metformin HCL.
BPH-TREATMENT- Finasteride, Tamsulosin.
ANTI-EMETICS - Domperidone Base/Maleate, Ondansetron HCL.
ANTI-ULCERANTS - Lansoprazole Powder/Pellets, Omeprazole Powder/Pellets, Pantoprazole Sodium, Rabeprazole Sodium.
ANTI-RETROVIRALS- Abacavir, Didanosine, Efavirenz, Indinavir, Lamivudine, Lopinavir, Nelfinavir, Mesylate, Nevirapine, Ritonavir,
Saquinavir, Stavudine , Zidovudine .
ANTI-VIRALS - Ribavirin.
MACROLIDES- Azithromycin Monohydrate.
ANTI-FUNGALS - Fluconazole, Terbinafine HCl.
QUINOLONES- Ciprofloxacin HCL, Moxifloxacin
ANTI-HISTAMINES - Fexofenadine
ANTI-OSTEOPOROSIS -Alendronate Sodium

General Information




  • Type:

    ISO 9001


Aurobindo Pharma acquires Actavis operations in 7 European countries


Hyderabad: Aurobindo Pharma Ltd has completed the acquisition of certain commercial operations in Western Europe from Actavis Plc. In January this year, the Hyderabad-based Aurobindo Pharma had signed an agreement with Actavis to acquire its personnel, commercial infrastructure, products, marketing authorisations and dossier licence rights in seven European countries for €30 million.

Both companies had also inked a long-term commercial and supply arrangement.

“The acquisition will make Aurobindo one of the leading Indian pharmaceutical companies in Europe with a top 10 position in several key markets,’’ Muralidharan, Senior Vice-President of European operations for Aurobindo, said here on Tuesday.

Smooth transition

Aurobindo would work to combine the strength of both enterprises in these markets and to identify and maximise all opportunities.

“We will continue to collaborate with Actavis to ensure business continuity and a smooth transition. In parallel, we will work closely with the acquired management teams to achieve a rapid and successful integration,’’ he added. Aurobindo’s scrip gained 4.67 per cent on BSE on Tuesday to end at Rs. 534.70.

Disclaimer: Orignal source from IBEF


  • On site

    Not declared 

  • Company

    More than 5000 Employees


  • 2014

    Over 500 million INR

Financial ratios

  • Turnover


  • K. Ragunathan

    Director & Non-Executive Chairman

  • K. R.

    Director & Vice Chairman

  • P. R.

    Non-Executive Director

  • N. G.

    Managing Director

Aurobindo Pharma Limited > Activities

  • Producer
  • Distributor
  • Service provider

You might also like:

Do you manage a company?

Register your company on Kompass for free to enhance your online presence. Contact potential prospects to help develop and build your business.

Register your company for free